Accessibility Menu
 
Immatics logo

Immatics

(NASDAQ) IMTX

Current Price$10.51
Market Cap$1.46B
Since IPO (2018)+13%
5 Year+1%
1 Year+132%
1 Month-1%

Immatics Financials at a Glance

Market Cap

$1.46B

Revenue (TTM)

$37.42M

Net Income (TTM)

$215.36M

EPS (TTM)

$-1.97

P/E Ratio

-5.51

Dividend

$0.00

Beta (Volatility)

1.02 (Average)

Price

$10.51

Volume

235,820.471

Open

$10.87

Previous Close

$10.87

Daily Range

$10.50 - $11.00

52-Week Range

$4.63 - $12.41

IMTX: Motley Fool Moneyball Superscore

58

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Immatics

Industry

Biotechnology

Employees

407

CEO

Harpreet Singh-Jasuja, PhD

Headquarters

Tübingen, 72076, DE

IMTX Financials

Key Financial Metrics (TTM)

Gross Margin

79%

Operating Margin

-6%

Net Income Margin

-6%

Return on Equity

-45%

Return on Capital

-44%

Return on Assets

-40%

Earnings Yield

-18.15%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.46B

Shares Outstanding

134.06M

Volume

235.82K

Avg. Volume

474.30K

Financials (TTM)

Gross Profit

$48.27M

Operating Income

$182.02M

EBITDA

$185.09M

Operating Cash Flow

$169.66M

Capital Expenditure

$6.30M

Free Cash Flow

$175.95M

Cash & ST Invst.

$469.14M

Total Debt

$15.63M

Immatics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$7.74M

-58.4%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$1.46B

N/A

Market Cap/Employee

$2.63M

N/A

Employees

554

N/A

Net Income

$58.76M

-47.4%

EBITDA

$64.35M

-71.8%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$438.95M

-16.5%

Accounts Receivable

$4.82M

-26.7%

Inventory

$0.00

N/A

Long Term Debt

$12.49M

-18.6%

Short Term Debt

$2.61M

-14.3%

Return on Assets

-39.60%

N/A

Return on Invested Capital

-43.77%

N/A

Free Cash Flow

$43.51M

-16.5%

Operating Cash Flow

$42.73M

-24.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
INBXInhibrx Biosciences, Inc.
$104.11-4.17%
NKTRNektar Therapeutics
$66.97-5.17%
TRMLTourmaline Bio, Inc.
$47.98+0.00%
PGENPrecigen, Inc.
$4.07-8.03%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$14.02-0.07%
POETPoet Technologies
$13.73-0.14%
FFord Motor Company
$13.05-0.03%
IBITiShares Bitcoin Trust
$43.25-0.04%

Questions About IMTX

What is the current price of Immatics?

Immatics is trading at $10.50 per share.

What is the 52-week range for Immatics?

Over the past 52 weeks, Immatics has traded between $4.63 and $12.41.

How much debt does Immatics have?

As of the most recent reporting period, Immatics reported total debt of $17.38M.

How much cash does Immatics have on hand?

Immatics reported $347.19M in cash and cash equivalents in its most recent financial results.

What is Immatics’s dividend yield?

Immatics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.